Chgb (511-532) (Rat) [1880]
Chgb (511-532) (Rat)
| SMILES |
CC(C)CC(NC(=O)C(C)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(N)CCCCN)C(=O)NC(Cc1ccccc1)C(=O)NC(CC(N)=O)C(=O)N1CCCC1C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CC(=O)O)C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCCCN)C(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NC(Cc1ccccc1)C(=O)NC(CCC(=O)O)C(=O)O |
| InChIKey |
USZLWOIXWADXRT-UHFFFAOYSA-N |
| Sequence |
KRLGALFNPYFDPLQWKNSDFE |
| HELM |
PEPTIDE1{K.R.L.G.A.L.F.N.P.Y.F.D.P.L.Q.W.K.N.S.D.F.E}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
None |
| Hydrogen bond donors |
None |
| Rotatable bonds |
None |
| Log P |
None |
| Molecular weight (Da) |
None |
No bioactivity data available.
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.